UK’s post-Brexit strategy looks to life sciences industry
August 30, 2017Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical
The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …
FDA fast-tracks recreational drug MDMA for treatment of PTSD
August 30, 2017Research and Development, Sales and Marketing FDA, MDMA, PTSD, life sciences, pharma, pharmaceuticals
In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to …
The September 2017 issue of Pharmafocus is now live!
August 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, MSD, Pharmafocus, President trump, Takeda, Trump, charlottesville, life sciences, oncology, pharmaceuticals, phatma
The September edition of Pharmafocus is now available – click here to read online.
AstraZeneca unloads another drug for $400m
August 29, 2017Research and Development, Sales and Marketing AstraZeneca, Takeda, biotech, drugs, pharma, pharmaceutical
AstraZeneca has had to do a serious re-think of its portfolio post-Mystic failure and it has made another move to …
Novartis names new Chief Digital Officer
August 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment
Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …
Thyroid disorders: An illness underestimated
August 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dr Bogumila Urgatz, Medical Director, Department Global Medical Affairs & General Medicine and Endocrinology, Merck KGaA discusses thryoid problems and …
New research reports first-ever response of central nervous tumour to CAR T therapy
August 29, 2017Manufacturing and Production, Research and Development CAR T, CAR-T, Cancer, life sciences, lymphoma, medicine, pharma, pharmaceuticals
Researchers at a General Hospital in Massachusetts has reported what they claim is the first response of a nervous system …
Novartis’ drug prevents heart attacks and cancer but faces major challenges
August 29, 2017Manufacturing and Production, Research and Development Novartis, biotech, drugs, pharma, pharmaceutical
It would be expected that when a company releases data to show that its drug, previously only used in a …
MSD scores trial success in reducing cardiovascular risk
August 29, 2017Manufacturing and Production, Research and Development MSD, heart attack, heart disease, life sciences, pharma, pharmaceutical
New data on MSD’s anacetrapib has revealed that the drug was able to reduce risk of the risk of major …
Gilead captures Kite in $11.9bn deal
August 29, 2017Manufacturing and Production, Sales and Marketing Gilead, biotech, drugs, kite pharma, pharma, pharmaceutical
Gilead had long been expected to make a serious acquisition to boost flagging growth and it finally made a move …
AstraZeneca invests “tens of millions” into Cheshire, UK manufacturing site
August 29, 2017Manufacturing and Production, Research and Development AZ, AstraZeneca, Cheshire, Chesire, UK, life sciences, pharma, pharmaceuticals
AstraZeneca has announced plans to invest a multi-million sum into its £150 million facility in Macclesfield, Chesire, UK – a …
Lithium levels in water supply could prevent dementia
August 25, 2017Research and Development biotech, drugs, lithium, pharma, pharmaceutical
Lithium has long been used in the treatment of people living with bipolar disorder and animal studies have found potential …
Top Ten most popular articles on Pharmafile.com this week
August 25, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medicine, pharma, pharmaceutical, top ten
As much as it might try, the pharmaceutical industry just isn’t able to keep the drug pricing debate out of …
The pharmacovigilance market dynamic
August 25, 2017Medical Communications biotech, drugs, pharma, pharmaceutical, pharmacoviglance
Pharmacovigilance is a science of understanding drug safety through identification, assessment, and prevention of adverse drug reactions (ADRs). It is …
Seven years later, EC gives approval for Merck KGaA’s MS drug
August 25, 2017Medical Communications, Sales and Marketing Mavenclad, Merck KGaA, biotech, drugs, multiple sclerosis, pharma, pharmaceutical
In 2011, Merck KGaA had all but given up on its MS drug after having been knocked back by both …
Samsung completes hat-trick of big biosimilar approvals
August 25, 2017Medical Communications, Sales and Marketing Biogen, Samsung Bioepis, biosimilars, biotech, drugs, pharma, pharmaceutical
Samsung Bioepis has announced that it, alongside its partner Biogen, has secured European Commission approval for its biosimilar version of …
‘Trade secret information’ to be shared between EMA and FDA
August 25, 2017Manufacturing and Production, Medical Communications EMA, FDA, biotech, drugs, pharma, pharmaceutical
As part of the on-going harmonisation of manufacturing standards across the Atlantic, the EMA and FDA have announced that they …
Roche receives FDA Priority Review for drug with potted history
August 24, 2017Sales and Marketing Roche, biotech, drugs, emicizumab, pharma, pharmaceutical
Roche, alongside its subsidiary, Genentech, announced that it has received Priority Review for its haemophilia A drug, emicizumab, and that …
Extended use of AstraZeneca’s Brilinta reduces cardiovascular death risk
August 24, 2017Research and Development AstraZeneca, Brilinta, cardiovascular, heart attack, life sciences, pharma, pharmaceutical
New data for AstraZeneca’s blood thinner Brilinta (ticagrelor) has shown that extended use of the drug can cut the risk …
HIV home tests seized from market over potential risk
August 24, 2017Sales and Marketing HIV, MHRA, biotech, drugs, pharma, pharmaceutical
The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
